Business Context and Reporting Period
This Form 8-K is a current report filed by MRI Interventions, Inc. (not Clearpoint Neuro, Inc.) on May 18, 2018, regarding events occurring on May 17, 2018. The filing addresses corporate governance changes involving the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Director Resignation: Maria Sainz resigned from the Board of Directors effective immediately on May 17, 2018.
- Reason for Departure: Ms. Sainz will not stand for reelection due to time commitments associated with her new role as Chief Executive Officer of Aegea Medical Inc., effective May 1, 2018.
- Board Composition: The Board size was reduced from seven members to six members.
- Committee Reassignments: Pascal E.R. Girin replaced Ms. Sainz on the Corporate Governance and Nominating Committee and the Compensation Committee. R. John Fletcher was appointed Chairman of the Corporate Governance and Nominating Committee.
- Compensatory Arrangement: The Compensation Committee approved an extension of the option exercise period for all stock options previously granted to Ms. Sainz, making the period coterminous with the term of the option award.
Guidance, Outlook, and Risks
The filing states that Ms. Sainz's resignation was voluntary and not the result of any disagreement with management, the Company, or its operations, policies, or practices. The Board believes the remaining members possess the necessary qualifications to provide oversight. No financial guidance, outlook, or specific risk factors were disclosed in this document.
Key Facts for Investor Verification
- Confirm the current composition of the Board of Directors and committee assignments following the reduction to six members.
- Verify the terms of the extended stock option exercise period granted to the departing director.
- Review the Company's proxy statement for the 2018 Annual Meeting to confirm the slate of nominees for reelection.